Add Yahoo as a preferred source to see more of our stories on Google. Inspire Sleep Apnea Innovation Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or ...

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...

Medicare Part B covers the cost of Inspire for sleep apnea and other FDA-approved medical devices as long as a doctor determines them to be medically essential for your care. For Original Medicare to ...

The gold standard for moderate to severe obstructive sleep apnea (OSA) is continuous positive airway pressure (CPAP) therapy. For a CPAP machine alone, it can cost anywhere from $500 to $1000 or more.

Inspire Medical Systems appoints Dr. Paul Hoff and Dr. Ruchir Patel as Vice President, Senior Medical Directors to enhance OSA treatment. Inspire Medical Systems, Inc. announced the appointment of two ...

ALSO BE AN INDICATION OF SLEEP APNEA CONCERNS. OTHER REPORTS LOOKS AT THE SLEEP TREATMENT THAT CAN GIVE YOU AND YOURS SOME LONG AWAITED, UNINTERRUPTED SLEEP. SNORING IS NOT JUST ANNOYING, IT CAN KEEP ...

At one point of time, there were at least three companies in the U.S. aiming to win FDA approval to launch an implantable neurostimulator to treat obstructive sleep apnea. Then there were just two.